LeafNLP Demos
Back to explore

Report #2884144

Received Feb 4, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
23 yrs
State
IN
Recovered
Unknown
Vaccinated
Jan 20, 2026
Onset
Jan 20, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALS15F244—

Symptoms (1)

Underdose

Symptom narrative

Administration of Less than the Recommended Dose of Engerix-B in Adults; Administration of Less than the Recommended Dose of Engerix-B in Adults; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 23-year-old female patient who received HBV (Engerix B pediatric) (batch number 5F244, expiry date 09-SEP-2027) for prophylaxis. On 20-JAN-2026, the patient received the 1st dose of Engerix B pediatric. On 20-JAN-2026, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: Administration of Less than the Recommended Dose of Engerix-B in Adults) and underdose (Verbatim: Administration of Less than the Recommended Dose of Engerix-B in Adults). The outcome of the adult use of a child product and underdose were not applicable. Additional Information: GSK Receipt Date: 23-JAN-2026 The vaccine administration facility was the same as the primary reporter.